|
Cardio-Oncology: Implications for Clinical Practice |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
|
Common Dermatologic Adverse Events in Oncology |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 0.75 Pharmacology
|
Live |
01/08/2026 - 2:55pm PST |
$0.00 |
|
Comprehensive Risk Assessment and Management Strategies for High-Risk Breast Cancer Patients |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
|
CRS/ICANS Unveiled: From Detection to Intervention |
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
|
Enduring |
|
$0.00 |
|
Current Approaches to Systemic Management of Regionally Advanced or Metastatic Melanoma |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Emory Fellows - Oncology 101(On-Demand) 2025 |
- 17.75 AMA PRA Category 1 Credit™
- 17.75 ANCC
- 4.75 Pharmacology
|
Enduring |
|
$0.00 |
|
Emory Fellows - Oncology 102: (On-Demand) 2025 |
- 19.25 AMA PRA Category 1 Credit™
- 19.25 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$0.00 |
|
Fertility Preservation Options Prior to Chemotherapy in Female Patients |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
|
Fred Hutch APP Onboarding Program - Oncology 102 |
- 19.25 AMA PRA Category 1 Credit™
- 19.25 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$150.00 |
|
From Data to Decisions: Appraising Clinical Trials for Real-World Practice |
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 0.25 Pharmacology
|
Enduring |
|
$0.00 |
|
From Slides to Strategy: Interpreting Pathology Reports for the Oncology APPs |
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 0.25 Pharmacology
|
Enduring |
|
$0.00 |
|
Head and Neck Cancers: Role of Radiation and Systemic Treatments, Side Effects and Management Strategies |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
|
Hematologic Malignancies: A Guide to the Clinical Impact of Staging and Risk Stratification Systems |
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 0.25 Pharmacology
|
Enduring |
|
$0.00 |
|
Identifying and Managing Common Immunotherapy-Related Adverse Events |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Incorporating Occupational Therapy into Cancer Care: Enhancing Independence and Quality of Life |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |